Pliant Therapeutics, Inc.

PLRX·NasdaqGS·Healthcare
Compare
0.8518−0.0089 (−1.03%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.8607
Open0.8600
Day range0.84160.8823
52-week range0.83001.8150
Off day high−3.46%
Off 52-week high−53.07%
Volume204.99K
Avg. volume (3M)398.63K
Market cap52.75M
EPS (TTM)-1.50
Forward P/E-0.66
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.36
Shares outstanding61.92M
Short interest7.66% of float
Earnings dateNov 12, 2026
Analyst target2.0000
Profit margin0.00%

Against its peers

Compare in full ›
PLRX BYSI PYPD PTX.AX PTN ONCY
Market cap 52.75M 27.92M 118.21M 60.62M 10.72M 55.70M
P/E (TTM) — — — — — —
Forward P/E -0.7 -1.4 -5.6 5.3 -3.2 -2.1
Price/book 0.4 -0.8 22.0 3.8 1.6 -8.7
Dividend yield — — — — — —
1-year change −47.50% −68.15% +44.06% +10.87% −19.69% −58.42%
Today −1.03% +9.34% +6.59% +3.92% +15.33% +8.92%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Pliant Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
BeyondSpring Inc.BYSI · Biotechnology 27.92M 0.6790 +9.34%
PolyPid Ltd.PYPD · Biotechnology 118.21M 5.82 +6.59%
Prescient Therapeutics LimitedPTX.AX · Biotechnology 60.62M 0.0530 +3.92%
Palatin Technologies, Inc.PTN · Biotechnology 10.72M 6.02 +15.33%
Oncolytics Biotech Inc.ONCY · Biotechnology 55.70M 0.4248 +8.92%
Helix BioPharma Corp.HBP.TO · Biotechnology 70.27M 0.9200 0.00%
ALX Oncology Holdings Inc.ALXO · Biotechnology 188.06M 1.3600 +5.43%
Compugen Ltd.CGEN · Biotechnology 192.29M 2.0300 +1.00%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
iBio, Inc.IBIO · San Diego, CA 51.45M 0.8000 −2.85%
MindWalk Holdings Corp.HYFT · Austin, TX 49.48M 1.0400 −5.45%
Eloxx Pharmaceuticals, Inc.ELOX · Arlington, MA 51.42M 12.74 −1.39%
Werewolf Therapeutics, Inc.HOWL · Watertown, MA 52.98M 1.0900 +1.87%
Arch Biopartners Inc.ARCH.V · Toronto, ON 58.42M 0.8600 −2.27%
Xlife Sciences AGXLS.SW · Zurich, Switzerland 50.40M 8.74 0.00%
Hansa Biopharma AB (publ)0RC7.IL · Lund, Sweden 58.79M 41.36 +4.82%
Heron Therapeutics, Inc.HRTX · Cary, NC 56.69M 0.2986 +4.88%

The stocks whose daily moves over the past year went most closely with Pliant Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Denali Therapeutics Inc.DNLI · Correlation 0.32 3.35B 20.96 +7.76%
MindWalk Holdings Corp.HYFT · Correlation 0.32 49.48M 1.0400 −5.45%

What visitors to Pliant Therapeutics's page also look at.

Company Mkt cap Price Today
Nkarta, Inc.NKTX 123.91M 1.7300 +13.07%
Passage Bio, Inc.PASG 11.29M 3.5100 +3.24%
Oric Pharmaceuticals, Inc.ORIC 968.12M 9.34 −2.61%
Stoke Therapeutics, Inc.STOK 1.78B 27.45 +1.70%
Black Diamond Therapeutics, IncBDTX 108.87M 1.9000 +4.97%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All PLRX news ›
Oncodaily - Oncology News·Positive

Pliant Therapeutics Announces Presentations at SITC 2026

Pliant Therapeutics shared on LinkedIn: “Pleased to announce presentations at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, the world’s largest cancer immunotherapy conference.” To which Society for Immunotherapy of…

PLRX
markets.businessinsider.com··2 outletsPositive

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid

More from 1 other outlet
markets.businessinsider.com··2 outletsPositive

Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer

Title: Selective targeting of integrins αvβ8 and αvβ1 improves anti-tumor responses mediated by immune checkpoint inhibition *The above presentation includes results that were obtained under a ... Pliant Therapeutics Announces…

SITC
More from 1 other outlet
MarketScreener··3 outletsPositive

Pliant Therapeutics, Inc. Announces Appointment of Craig Blanchette, Ph.D. as Senior Vice President, Research

Pliant Therapeutics, Inc. announced the appointment of Craig Blanchette, Ph.D., as Senior Vice President, Research . Dr. Blanchette is an accomplished biopharmaceutical research and development... announced the appointment of Craig…

PLRXPYPD
More from 2 other outlets

From the 4Search news index, newest first.

In the news

31mentions in 30 days
15with it in the headline
Positivesentiment

Mentioned with

Pliant Therapeutics, Inc.27Genentech24Duke University21University of Colorado Cancer Center18Neck Cancer Steering Committee17Astrazeneca16Gu) Committee16Johns Hopkins Hospital15

People in the coverage

Bernard Coulie23David Raben23Bob Dagher16Waqar Ahmed Siddiqui15Clinilabs11Eileen Mcauley10

Themes

People21Appoints19Therapeutics18Chief17Officer17C-Suite15Oncology15Finanzen12

Most coverage from

  1. marketscreener.com8
  2. prnewswire.com6
  3. markets.businessinsider.com5
  4. manilatimes.net2
  5. stocktitan.net2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance